Tuesday, February 06, 2024 1:19:11 PM
Linde Reports Full-Year and Fourth-Quarter 2023 Results
Full-Year Highlights
Sales $32.9 billion, down 2%, underlying sales up 5%
Operating profit $8.0 billion; adjusted operating profit $9.1 billion, up 15%
Operating profit margin 24.4%; adjusted operating profit margin 27.6%, up 390 basis points versus prior year
EPS $12.59; adjusted EPS $14.20, up 16%
Returned $6.4 billion to shareholders through dividends and share repurchases
Total project backlog of $8.5 billion
Fourth-Quarter Highlights
Sales $8.3 billion, up 5% YoY, underlying sales up 4%
Operating profit $2.0 billion, adjusted operating profit $2.3 billion, up 14%
Operating profit margin 24.4%; adjusted operating profit margin 27.4%, YoY up 210 basis points
EPS $3.16, up 18%; adjusted EPS $3.59, up 14%
2024 Guidance
First-quarter 2024 adjusted EPS guidance $3.58 - $3.68, represents 6%-9% growth ex. FX
Full-year 2024 adjusted EPS guidance $15.25 - $15.65, represents 8%-11% growth ex. FX
Recent LIN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/02/2024 02:16:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2024 10:37:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2024 05:18:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 07:10:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2024 07:00:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2024 06:56:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:55:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:33:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:32:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:28:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:36:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:25:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:21:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:19:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2024 02:10:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:59:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:57:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:46:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:41:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:40:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:35:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:33:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 07:12:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:56:23 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM